Skip links

Disclosures

Dr. Kim has served as a consultant for AbbVie, Inc., Cara Therapeutics, Concert Pharmaceuticals, Incyte Corporation, LEO Pharma, Menlo Therapeutics, and Pfizer, Inc. He has also participated on the advisory board for Cara Therapeutics, Celgene Corporation, Kiniksa Pharmaceuticals, Menlo Therapeutics, Regeneron Pharmaceuticals, Inc., Sanofi Genzyme, and Theravance Biopharma. He is also Founder, Chief Scientific Officer, and stockholder of Nuogen Pharma, Inc. He is a stockholder of Locus Biosciences. Dr. Kim has a patent pending for the use of JAK inhibitors for chronic itch. All other authors declare that they have no relevant conflicts of interest.

How it Works

Complete Form Online

Complete a quick and secure online questionnaire describing your itch history and condition

 

 

 

 

 

Medical Consultation

A board-certified physician will consult with you to develop a personalized management plan

 

 

Treatment & After Care

After treatment, our team of nurses will help you along the way with follow-up care

 

 

 

Access Insider Content

Gain access to our educational itch resources and exclusive insider content

 

 

Debilitating itch has finally met its match. Let’s get your life back.

Begin medical consultation